BDBM667106 N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H-pyrido[3,4- b][1,4]oxazin-1-yl]pyridin-2-yl}-2- {6-methyl-2,6- diazaspiro[3.3]heptan-2- yl}acetamide::US20240116947, Example 53

SMILES CN1CC2(C1)CN(CC(=O)Nc1cc(ccn1)N1CCOc3cnc(cc13)-c1cc(Cl)ccc1F)C2

InChI Key InChIKey=KYMDMBCJDBMOHK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667106   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM667106(US20240116947, Example 53 | N-{4-[7-(5-chloro-2-fl...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent